Latanoprost-induced changes in the iris and trabeculum: An electron-microscopic morphological study

被引：2

作者：

Yildirim N. ^{[1
]}

Sahin A. ^{[1
]}

Kara S. ^{[1
]}

Baycu C. ^{[2
]}

机构：

[1] Department of Ophthalmology, Eskisehir Osmangazi University, Faculty of Medicine, Meselik, Eskisehir

[2] Department of Histology and Embryology, Eskisehir Osmangazi University, Faculty of Medicine, Meselik, Eskisehir

来源：

International Ophthalmology | 2010年 / 30卷 / 1期

关键词：

Electron microscopy; Iris; Latanoprost; Trabeculum;

D O I：

10.1007/s10792-008-9285-4

中图分类号：

学科分类号：

摘要：

Purpose The purpose was to analyze the histological aspects of irises and trabeculums by transmission electron microscopy (TEM) in patients who had or had not received latanoprost therapy. Materials and methods Seven patients with pseudoexfoliation glaucoma were enrolled in the study. Four of them had been using latanoprost monotheraphy for 2 months. Iris samples were obtained by peripheral iridectomy. Trabeculum samples were obtained during the trabeculectomy without use of antimetabolites. The specimens were further processed for transmission electron microscopy. Results There was extracellular pigmentation in the iris stroma in four patients treated with latanoprost, whereas in the control group there was no free melanin in the stroma. Intracellular pigment in fibroblasts, melanocytes, or both was present in all samples in the study group. More pigment accumulation was found in the trabecular endothelial cells of the patients who had received latanoprost therapy. Conclusion Latanoprost therapy causes pigment accumulation in the iris and trabeculum of patients in short-term therapy. © 2009 Springer Science+Business Media B.V.

引用

页码：93 / 97

页数：4

共 21 条

[1]

Vesti E., Kivela T., Exfoliation syndrome and exfoliation glaucoma, Progress in Retinal and Eye Research, 19, 3, pp. 345-368, (2000)

[2]

Morrison J.C., Green W.R., Light microscopy of the exfoliation syndrome, Acta Ophthalmol (Copenh), 184, pp. 15-27, (1988)

[3]

Kuchle M., Schlotzer-Schrehardt U., Naumann G.O., Occurrence of pseudoexfoliative material in parabulbar structures in pseudoexfoliation syndrome, Acta Ophthalmol (Copenh), 69, pp. 124-130, (1991)

[4]

Ringvold A., On the occurrence of pseudo-exfoliation material in extrabulbar tissue from patients with pseudo-exfoliation syndrome of the eye, Acta Ophthalmol (Copenh), 51, pp. 411-418, (1973)

[5]

Schlotzer-Schrehardt U., Koca M.R., Naumann G.O., Volkholz H., Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder, Arch Ophthalmol, 110, pp. 1952-1956, (1992)

[6]

Camras C.B., Alm A., Watson P., Stjernschantz J., Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after one year of treatment in 198 patients. Latanoprost Study Groups, Ophthalmology, 103, pp. 1916-1924, (1996)

[7]

Yamamoto T., Kitazawa Y., Iris-color change developed after topical isopropyl unoprostone treatment, J Glaucoma, 6, pp. 430-432, (1997)

[8]

Goldberg I., Cunha-Vaz J., Jakobsen J.E., Nordmann J.P., Trost E., Sullivan E.K., Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with openangle glaucoma or ocular hypertension, J Glaucoma, 10, pp. 414-422, (2001)

[9]

Sherwood M., Brandt J., Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure, Survey of Ophthalmology, 45, SUPPL. 4, (2001)

[10]

Puska P., The amount of lens exfoliation and chamber-angle pigmentation in exfoliation syndrome with or without glaucoma, Acta Ophthalmol Scand, 74, pp. 202-204, (1996)

← 1 2 3 →